中国临床药理学杂志2017，Vol.33Issue(9)：853-856,4.DOI:10.13699/j.cnki.1001-6821.2017.09.023
抗痛风相关的高尿酸血症药物的研究进展
Advances in hyperuricemia drugs for gout treatment
陈晴 1铁远 2胡咏川 1刘蕾2
作者信息
- 1. 北京医院国家老年医学中心,北京100730
- 2. 北京大学医学部药学院药事管理与临床药学系,北京100191
- 折叠
摘要
Abstract
Persistent hyperuricemia is currently the most common cause of gout.New medications targeting the urate transporters in renal proximal tubule epithelial cells have become hot topics for gout treatment.The latest progress in hyperuricemia drugs for gout treatment was reviewed in this paper.关键词
黄嘌呤氧化酶抑制剂/嘌呤核苷磷酸化酶抑制剂/高尿酸血症/痛风Key words
xanthine oxidoreductase inhibitor/purine nucleoside phosphorylase inhibitor/hyperuricemia/gout分类
医药卫生引用本文复制引用
陈晴,铁远,胡咏川,刘蕾..抗痛风相关的高尿酸血症药物的研究进展[J].中国临床药理学杂志,2017,33(9):853-856,4.
